StockData
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30

PharmaCyte Biotech, Inc.

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.34+0.00 (+0.53%)

Close on Oct 19, 2026

Market cap
$3.67M
P/E (TTM)
–
Dividend yield
–

PharmaCyte Biotech, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

PharmaCyte Biotech does not break out revenue by segment, region or product in the tagged data of its filings for this period type.